Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis

T. Kalincik, V. Jokubaitis, T. Spelman, D. Horakova, E. Havrdova, M. Trojano, J. Lechner-Scott, A. Lugaresi, A. Prat, M. Girard, P. Duquette, P. Grammond, C. Solaro, F. Grand'Maison, R. Hupperts, J. Prevost, P. Sola, D. Ferraro, M. Terzi, E. Butler & 9 others M. Slee, A. Kermode, M. Fabis-Pedrini, P. McCombe, M. Barnett, C. Shaw, S. Hodgkinson, H. Butzkueven, MSBase Study Grp

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)596-597
Number of pages2
JournalMultiple Sclerosis
Volume23
Publication statusPublished - Oct 2017
Event7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) - Paris, France
Duration: 25 Oct 201728 Oct 2017

Cite this

Kalincik, T., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., ... MSBase Study Grp (2017). Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis. Multiple Sclerosis, 23, 596-597.
Kalincik, T. ; Jokubaitis, V. ; Spelman, T. ; Horakova, D. ; Havrdova, E. ; Trojano, M. ; Lechner-Scott, J. ; Lugaresi, A. ; Prat, A. ; Girard, M. ; Duquette, P. ; Grammond, P. ; Solaro, C. ; Grand'Maison, F. ; Hupperts, R. ; Prevost, J. ; Sola, P. ; Ferraro, D. ; Terzi, M. ; Butler, E. ; Slee, M. ; Kermode, A. ; Fabis-Pedrini, M. ; McCombe, P. ; Barnett, M. ; Shaw, C. ; Hodgkinson, S. ; Butzkueven, H. ; MSBase Study Grp. / Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis. In: Multiple Sclerosis. 2017 ; Vol. 23. pp. 596-597.
@article{36505322ed9241398c237831a7fb9416,
title = "Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis",
author = "T. Kalincik and V. Jokubaitis and T. Spelman and D. Horakova and E. Havrdova and M. Trojano and J. Lechner-Scott and A. Lugaresi and A. Prat and M. Girard and P. Duquette and P. Grammond and C. Solaro and F. Grand'Maison and R. Hupperts and J. Prevost and P. Sola and D. Ferraro and M. Terzi and E. Butler and M. Slee and A. Kermode and M. Fabis-Pedrini and P. McCombe and M. Barnett and C. Shaw and S. Hodgkinson and H. Butzkueven and {MSBase Study Grp}",
year = "2017",
month = "10",
language = "English",
volume = "23",
pages = "596--597",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",

}

Kalincik, T, Jokubaitis, V, Spelman, T, Horakova, D, Havrdova, E, Trojano, M, Lechner-Scott, J, Lugaresi, A, Prat, A, Girard, M, Duquette, P, Grammond, P, Solaro, C, Grand'Maison, F, Hupperts, R, Prevost, J, Sola, P, Ferraro, D, Terzi, M, Butler, E, Slee, M, Kermode, A, Fabis-Pedrini, M, McCombe, P, Barnett, M, Shaw, C, Hodgkinson, S, Butzkueven, H & MSBase Study Grp 2017, 'Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis' Multiple Sclerosis, vol. 23, pp. 596-597.

Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis. / Kalincik, T.; Jokubaitis, V.; Spelman, T.; Horakova, D.; Havrdova, E.; Trojano, M.; Lechner-Scott, J.; Lugaresi, A.; Prat, A.; Girard, M.; Duquette, P.; Grammond, P.; Solaro, C.; Grand'Maison, F.; Hupperts, R.; Prevost, J.; Sola, P.; Ferraro, D.; Terzi, M.; Butler, E.; Slee, M.; Kermode, A.; Fabis-Pedrini, M.; McCombe, P.; Barnett, M.; Shaw, C.; Hodgkinson, S.; Butzkueven, H.; MSBase Study Grp.

In: Multiple Sclerosis, Vol. 23, 10.2017, p. 596-597.

Research output: Contribution to journalAbstract/Meeting Abstract

TY - JOUR

T1 - Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis

AU - Kalincik, T.

AU - Jokubaitis, V.

AU - Spelman, T.

AU - Horakova, D.

AU - Havrdova, E.

AU - Trojano, M.

AU - Lechner-Scott, J.

AU - Lugaresi, A.

AU - Prat, A.

AU - Girard, M.

AU - Duquette, P.

AU - Grammond, P.

AU - Solaro, C.

AU - Grand'Maison, F.

AU - Hupperts, R.

AU - Prevost, J.

AU - Sola, P.

AU - Ferraro, D.

AU - Terzi, M.

AU - Butler, E.

AU - Slee, M.

AU - Kermode, A.

AU - Fabis-Pedrini, M.

AU - McCombe, P.

AU - Barnett, M.

AU - Shaw, C.

AU - Hodgkinson, S.

AU - Butzkueven, H.

AU - MSBase Study Grp

PY - 2017/10

Y1 - 2017/10

M3 - Abstract/Meeting Abstract

VL - 23

SP - 596

EP - 597

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

ER -

Kalincik T, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M et al. Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis. Multiple Sclerosis. 2017 Oct;23:596-597.